| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Japan. * To whom correspondence should be addressed. E-mail: morishit{at}cgt.med.osaka-u.ac.jp.
Is Vascular Endothelial Growth Factor a Missing Link Between Hypertension and Inflammation?
Ryuichi Morishita*
This article has been cited by other articles:
![]() |
X. Wang, S. Cheng, V. H. Brophy, H. A. Erlich, C. Mannhalter, K. Berger, W. Lalouschek, W. S. Browner, Y. Shi, E. B. Ringelstein, et al. A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations: Association of Lymphotoxin-Alpha in Nonhypertensive Patients Stroke, March 1, 2009; 40(3): 683 - 695. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |